Moderna Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 122.4% | 33.0% | 57.5% | 52.0% | 27.7% | 77.3% | 84.1% | 83.8% | 99.2% | 66.7% | 245.5% | 64.1% | 112.6% | |
| -22.4% | 67.0% | 42.5% | 48.0% | 72.3% | 22.7% | 15.9% | 16.2% | 0.8% | 33.3% | -145.5% | 35.9% | -12.6% | |
| 63.4% | 50.0% | 615.0% | 552.5% | 61.3% | 117.4% | 800.0% | 493.0% | 78.8% | 114.3% | 166.8% | 449.0% | 129.1% | |
| 24.1% | 9.5% | 164.1% | 121.3% | 15.1% | 36.7% | 198.1% | 162.0% | 26.4% | 45.4% | 44.5% | 149.0% | 43.3% | |
| 87.5% | 66.8% | 800.6% | 664.7% | 76.1% | 153.0% | 997.2% | 654.9% | 26.4% | 159.7% | 211.3% | 597.9% | 136.4% | |
| -109.9% | 0.2% | -758.1% | -616.7% | -3.8% | -130.3% | -981.3% | -638.7% | -25.6% | -126.4% | -356.8% | -562.1% | -149.0% | |
| 0.5% | 0.2% | 3.6% | 2.7% | 0.3% | 0.6% | 0.9% | 0.7% | 0.0% | 1.2% | 4.4% | 11.7% | 1.9% | |
| -106.9% | 2.5% | -697.6% | -578.7% | 1.1% | -123.8% | -900.9% | -576.1% | -18.4% | -117.8% | -342.9% | -529.0% | -138.6% | |
| 91.3% | -5.2% | 6.0% | – | 0.4% | -6.7% | 6.5% | 4.9% | 1.3% | 4.0% | 2.3% | 10.3% | 2.9% | |
| -198.3% | 7.7% | -703.6% | -578.7% | 0.7% | -117.2% | -907.5% | -581.0% | -19.7% | -121.8% | -345.2% | -539.3% | -141.4% | |
| -92.8% | 9.9% | -672.5% | -557.5% | 4.3% | -116.9% | -863.6% | -535.2% | -13.3% | -108.0% | -323.4% | -485.5% | -127.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.